Research Articles | Page 90 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Long-term outcome of fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria May 2014 Biol Blood Marrow Transplant paroxysmal nocturnal hemoglobinuria (PNH)
Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myeloid leukemia following aplastic anemia Dec 2013 Biol Blood Marrow Transplant aplastic anemia
Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to MDS or Leukemia from Severe Aplastic Anemia. A report by the MDS subcommittee of the chronic malignancies working party (CMWP) and the severe aplastic anemia working party (WPSAA) Jun 2014 Biol Blood Marrow Transplant aplastic anemia
Consider Allogeneic Bone Marrow Transplantation for Older, Fit Patients with Aplastic Anemia Jan 2019 Biol Blood Marrow Transplant aplastic anemia
Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria Apr 2012 BioDrugs paroxysmal nocturnal hemoglobinuria (PNH)
Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): Why hypercellular marrow strongly favors accelerated apoptosis. Mar 2013 Biochem Cell Biol myelodysplastic syndromes (MDS)
Clonal Hematopoiesis and therapy related MDS/AML Mar 2019 Best Practice & Research. Clinical Heamatology myelodysplastic syndromes (MDS)
Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a "Catch-All" Term? Jun 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? May 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS)
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading? Dec 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS)
Share with addtoany.com.